Press Release Distribution & PR Platform - ACCESS Newswire
11 hours ago • Google News
BioXcel Therapeutics Inc (BTAI)
US$ 1.8110.37%
Price Chart
Key Statistics
Market Cap
$ 10.23M
P/E Ratio
0.00
Revenue (TTM)
$ 2.27M
Volume
75.8K
52W High
$ 43.12
52W Low
$ 1.29
Dividend Yield
0.00%
Beta
0.64
Technicals
50-Day MA
2.1442
200-Day MA
7.726
52 Week High
43.12
52 Week Low
1.29
About BTAI
BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in n.
Employees
37
Headquarters
New Haven, CT
CEO
Dr. Vimal D. Mehta Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg